NGMBIO

Serial Number 97341671
732

Registration Progress

Application Filed
Mar 31, 2022
Under Examination
Jun 6, 2023
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered

Basic Information

Serial Number
97341671
Filing Date
March 31, 2022
Published for Opposition
April 11, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
732
Status Date
Nov 18, 2024
Application
Pending
Classes
005 042 044

Rights Holder

NGM Biopharmaceuticals, Inc.

03
Address
333 Oyster Point Boulevard
South San Francisco, CA 94080

Ownership History

NGM Biopharmaceuticals, Inc.

Original Applicant
03
South San Francisco, CA

NGM Biopharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Ilene B. Tannen

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description
Nov 18, 2024 EX3G S SOU EXTENSION 3 GRANTED
Nov 18, 2024 EXT3 S SOU EXTENSION 3 FILED
Nov 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2024 EX2G S SOU EXTENSION 2 GRANTED
May 23, 2024 EXT2 S SOU EXTENSION 2 FILED
May 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2023 EX1G S SOU EXTENSION 1 GRANTED
Nov 17, 2023 EXT1 S SOU EXTENSION 1 FILED
Nov 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 6, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 2, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2022 GNRT F NON-FINAL ACTION E-MAILED
Aug 10, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 4, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 7, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases

Additional Information

Design Mark
The mark consists of the letters "NGM BIO" within a horizontal oval which contains a swooping stripe going through it on the right side.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"